Evan Beckman,Graham K. Farrington,Werner Meier,Jeffrey L. Browning
申请号：
US12560257
公开号：
US08338376B2
申请日:
2009.09.15
申请国别(地区):
US
年份:
2012
代理人:
摘要：
This invention relates to methods of treating disease with soluble inhibitors of the lymphotoxin pathway having improved properties. This invention also relates to improved LTBR-Ig fusion proteins, and pharmaceutical compositions thereof.
